These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39322401)

  • 21. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA TRHDE-AS1 and MiR-1275 as Promising Prognostic Biomarkers and Effects on Tumor Cell Progression in Gastric Cancer.
    Liu F; Cui J; Xue D
    Tohoku J Exp Med; 2023 Sep; 261(1):13-23. PubMed ID: 36792178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL14 contributes to the progression of nasopharyngeal carcinoma through regulating the stability of AOC1 mRNA.
    Hu C; Song S; Zhao S; Xue Z; Zhu X
    Hereditas; 2024 Jul; 161(1):20. PubMed ID: 38956710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1.
    Hu S; Zheng W; Jin L
    J Nat Med; 2021 Jan; 75(1):156-166. PubMed ID: 33219447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma.
    Rong M; Zhang M; Dong F; Wu K; Cai B; Niu J; Yang L; Li Z; Lu HY
    Cancer Cell Int; 2024 Mar; 24(1):113. PubMed ID: 38528591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
    Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Tian Q; Huang J; Zhang Q; Zhao J
    Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL3-mediated m
    Cheng X; Yang H; Chen Y; Zeng Z; Liu Y; Zhou X; Zhang C; Xie A; Wang G
    Cell Mol Biol Lett; 2024 Aug; 29(1):109. PubMed ID: 39143552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
    Cui S
    J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL14 promotes chondrocyte ferroptosis in osteoarthritis via m6A modification of GPX4.
    Liu D; Ren L; Liu J
    Int J Rheum Dis; 2024 Aug; 27(8):e15297. PubMed ID: 39175261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
    Fan L; Li H; Wang W
    Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
    Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
    Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer.
    Wang J; Fan P; Shen P; Fan C; Zhao P; Yao Shen ; Dong K; Ling R; Chen S; Zhang J
    Cancer Lett; 2024 Aug; 596():216846. PubMed ID: 38582397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1.
    Shi Z; Pu W; Li M; Aihemaitijiang M; Li S; Zhang X; Liu B; Sun M; Li J; Li Z
    Mol Med; 2024 Oct; 30(1):179. PubMed ID: 39425009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.